Australian Primary Hemp (ASX:APH) - Co founder & CEO, Charles Mann (left), Co founder & Chief Operating Officer, James Hood (right)
Co founder & CEO, Charles Mann (left), Co founder & Chief Operating Officer, James Hood (right)
Sourced: The Weekly Times
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Australian Primary Hemp (APH) Co-founder and CEO Charles Mann has resigned to pursue other opportunities
  • Taking his place, is Neale Joseph who started just a few months ago as the Head of Product
  • Neale has vast leadership experience, having successfully led businesses across several countries
  • APH is down 5.56 per cent on the market this afternoon, trading at 8.5¢ apiece

Australian Primary Hemp’s (APH) co-founder and CEO, Charles Mann, has resigned to pursue other opportunities.

He has also resigned his seat on the board, effective immediately however Charles will be assisting with the handover during his notice period.

APH’s other founder, James Hood, will remain on the board and as Chief Operating Officer. The company says James is fully committed to the business.

The company has already transitioned Head of Product, Neale Joseph, as new CEO with an immediate start.

Neale joined the company just a few months ago but is an experienced CEO. He has successfully led businesses across Australia, New Zealand, the Asia Pacific and the Middle East.

He recently co-founded a successful start-up in the natural health and beauty industry.

Neale previously worked with companies such as Pure Beauty Australia and David Jones.

“APH is delighted to appoint Neale Joseph as CEO, having already made a large impact to the organisation during his short time at APH,” Chairman Cameron Petricevic said.

“Neale has both impressive experience and a proven track record that are perfectly suited to APH’s current stage of development and potential. With his appointment, APH is well-positioned to accelerate growth,” he added.

APH is down 5.56 per cent on the market this afternoon, trading at 8.5¢ apiece at 1:10pm AEDT.

APH by the numbers
More From The Market Online

Firebrick Pharma’s US launch of Nasal Spray is nothing to be sneezed at

Australian pharmaceutical developer, Firebrick Pharma (ASX:FRE) has launched its latest product, Nasodine Nasal Spray, in the…

AVITA Medical drops revenue forecast for Q1

AVITA Medical (ASX:AVH) provided an update on its anticipated revenue for Q1 2024 - and has…

Little Green Pharma heading into Q2 cashed up after record sales

Little Green Pharma (ASX:LGP) wound up Q1CY24 with $5M in cash after posting record sales of…

Recce Pharmaceuticals up 6% on new antibiotic production milestone

Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch…